228 related articles for article (PubMed ID: 16835400)
1. The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
Zanchi A; Perregaux C; Maillard M; Cefai D; Nussberger J; Burnier M
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1228-34. PubMed ID: 16835400
[TBL] [Abstract][Full Text] [Related]
2. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
3. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
Husková Z; Kramer HJ; Vanourková Z; Cervenka L
J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
[TBL] [Abstract][Full Text] [Related]
4. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Gaikwad AB; Viswanad B; Ramarao P
Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
[TBL] [Abstract][Full Text] [Related]
5. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell.
Imanishi T; Kobayashi K; Kuroi A; Ikejima H; Akasaka T
Hypertens Res; 2008 Apr; 31(4):757-65. PubMed ID: 18633188
[TBL] [Abstract][Full Text] [Related]
7. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
[TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Jan; 31(1):117-25. PubMed ID: 18360026
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
11. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
Henriksen K; Byrjalsen I; Nielsen RH; Madsen AN; Larsen LK; Christiansen C; Beck-Nielsen H; Karsdal MA
Eur J Pharmacol; 2009 Aug; 616(1-3):340-5. PubMed ID: 19595686
[TBL] [Abstract][Full Text] [Related]
12. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin-angiotensin system.
Leandro SM; Furukawa LN; Shimizu MH; Casarini DE; Seguro AC; Patriarca G; Coelho MS; Dolnikoff MS; Heimann JC
Physiol Behav; 2008 Sep; 95(1-2):145-51. PubMed ID: 18572207
[TBL] [Abstract][Full Text] [Related]
13. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
14. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
15. High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.
Min Q; Bai YT; Jia G; Wu J; Xiang JZ
Exp Mol Pathol; 2010 Feb; 88(1):133-7. PubMed ID: 19796634
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
El Midaoui A; Wu L; Wang R; de Champlain J
Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
[TBL] [Abstract][Full Text] [Related]
17. [Effects of high salt diet on blood pressure, renal morphology and osteopontin expression in Sprague-Dawley rat with Ang II-induced renal injury].
Zheng Y; Liu ZQ; Ye T; He L; Wang Y; Fang Y; Li JN; Liu P; Ye F
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):827-32. PubMed ID: 16027079
[TBL] [Abstract][Full Text] [Related]
18. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
20. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
